Pediatric lung adenocarcinoma is rare, but has been reported in patients with nonpulmonary childhood cancers.1, 2, 3 We report a case of a 17-year-old male who developed pulmonary adenocarcinoma with ALK receptor tyrosine kinase (ALK) rearrangement following neuroblastoma therapy. READ ARTICLE
Journal of Thoracic Oncology DOI:10.1016/j.jtho.2019.02.010
Authors: Yazeed Alwelaie, Rebecca J. Deyell, Helen R. Nadel, Tracy Tucker, Janessa Laskin, S. Rod Rassekh, Chen Zhou, John C. English, Anna F. Lee